Many people choose to get vaccinated against COVID-19 because health authorities insist they reduce a person’s risk of experiencing a more severe case of the virus. However, data from Israel indica…
dreddymd.com
Many people choose to get vaccinated against COVID-19 because health authorities insist they reduce a person’s risk of experiencing a more severe case of the virus. However, data from Israel indicates this may not be the case.
In fact, most of the severe cases of the virus at one of the country’s biggest hospital complexes are being found in people who have received at least three doses of the vaccine. This is according to the hospital’s coronavirus ward director.
Israel is an interesting place to study this type of data because it has one of the greatest rates of vaccination in the world at around 90%. Moreover, many of the country’s high-risk patients have even received a fourth shot.
Professor Yaakov Jerris of the
Tel Aviv Sourasky Medical Center – Ichilov Hospital, the country’s second-biggest hospital, said that between
70 and 80 percent of the serious cases they are currently seeing are among vaccinated individuals.
He added: “So, the vaccine has no significance regarding severe illness, which is why just 20 to 25 percent of our patients are unvaccinated.”
Vaccines may not protect against serious illness, but vitamin D helps
However, Israeli scientists have revealed one very helpful piece of information. They say they have now obtained the most convincing evidence yet that
vitamin D supplements can help patients with COVID-19 to reduce their risk of serious illness or death.
Using research that was carried out during the country’s first two waves of the virus, which was before the vaccines were available,
the peer-reviewed study by researchers from the Galilee Medical Center and Bar-Ilan University said the impact of vitamin D was so strong that they could actually predict just how well infected patients would fare simply by looking at their ages and vitamin D levels. The study was published in the journal
PLOS One.